Integrated Solution
Full process·Multi technology·High guarantee
Wantai BioPharm Blood Safety Testing Solution is committed to providing customers of blood collection and supply institutions with full process blood safety testing guarantees. The existing products cover a series of products such as colloidal gold, enzyme-linked immunosorbent assay, chemiluminescence, nucleic acid blood screening, assembly line and third-party quality control products, which have fully covered the entire process of "collection-testing-use".
Multi technology and multi platform collaborative testing provides a closed-loop product solution for improving the safety, laboratory efficiency, and quality control of clinical blood transfusion patients and blood products, helping blood collection and supply institutions take blood safety testing to a new level.
Comprehensive security guarantee
Combined detection with multiple technology platforms provides full-link security guarantees from blood collection to clinical use, conducts comprehensive screening of pathogens, and ensures transfusion safety.
Efficient detection process
The seamless integration of automated assembly lines and information systems enables efficient operation of the testing process, shortens testing time, reduces human errors, and improves overall laboratory efficiency.
Quality traceability system
The whole process quality control and traceability system covers all aspects of blood collection and use, achieving full process quality monitoring and traceability of each unit of blood.
Professional technical support
A professional team provides comprehensive support services such as technical training, method validation, and quality system construction to assist blood collection and supply institutions in continuously improving their testing capabilities.
Whole process blood safety solution
From blood collection to clinical use, Wantai Biotechnology provides professional support for every step
Before blood donation
Standardized pre-donation screening and management ensure the safety of blood sources.
After blood donation
Comprehensive detection with multiple platforms to ensure the accuracy and reliability of test results.
Before blood transfusion
Strict testing of a series of blood-transfusion parameters to ensure the safety of clinical blood transfusion.
Donor screening
Standardized health assessment and preliminary screening processes for blood donors to exclude high-risk groups in advance and ensure the safety of blood sources.
Multi-platform detection
Collaborative detection using multiple technology platforms such as colloidal gold, enzyme-linked immunosorbent assay, chemiluminescence, and nucleic acid blood screening to comprehensively screen for infectious disease markers.
Quality control
A complete quality-control system and monitoring with third-party quality-control products to continuously monitor the quality of the testing process and results and ensure blood safety.
Comprehensive product solution
Multiple detection technology platforms to meet the needs of blood collection and supply institutions of different scales and the blood transfusion departments of hospitals.
Rapid inspection
Colloidal gold
  • Results can be obtained rapidly within 15 to 30 minutes, suitable for emergency screening and preliminary screening.
  • Easy to operate, no professional equipment is required, suitable for use at the grassroots level.
  • It covers infectious disease markers such as HBV, HCV, HIV, and TP.
Central Laboratory inspection
Enzyme-linked immunosorbent assay
  • Low cost, with low requirements for equipment and environment, and widely applied.
  • High degree of automation, suitable for batch testing and improving efficiency.
  • Complete testing parameters for infectious diseases such as HBV/HCV/HIV/TP.
Chemiluminescence
  • High sensitivity, few interfering factors, and a wide linear range.
  • Low background value, high signal-to-noise ratio, and high degree of automation.
  • Fast testing speed, stable testing, and not easily interfered by other external factors.
Nucleic acid blood screening
  • Directly detect viral nucleic acids, further shorten the window period, and provide the highest level of safety.
  • Multiple detection technologies, capable of simultaneously detecting multiple pathogens.
  • Automated workstation, reducing the risk of contamination and improving the accuracy of testing.
Automated production line
  • Fully automated sample processing and testing production line to improve work efficiency.
  • Modular design, flexible configuration, and adaptation to the needs of different scales.
  • Information system integration, realizing automatic review and reporting of test results.
Quality control management
Internal quality control, external quality assessment, performance verification
  • Third-party quality control products and performance verification serum panels to ensure testing quality.
  • Quality management software, automatically analyzing quality control data and giving early warnings of abnormalities.
  • Complete quality management system construction plan and technical support.
For more information :  wtexport@ystwt.com